i-SENS Inc (099190) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.018x

Based on the latest financial reports, i-SENS Inc (099190) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.18 Billion ≈ $4.19 Million USD) by net assets (₩345.35 Billion ≈ $234.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

i-SENS Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how i-SENS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read i-SENS Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

i-SENS Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of i-SENS Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Catella AB (publ)
ST:CAT-B
0.009x
United Pharm
KO:033270
0.051x
Quang Viet Enterprise Co Ltd
TW:4438
-0.025x
SNS
KLSE:0259
-0.411x
Atomera Inc
NASDAQ:ATOM
-0.175x
Aurora Cannabis Inc
NASDAQ:ACB
0.030x
Samara Asset Group
F:SRAG
N/A
Mechema Chemicals Int
TWO:4721
0.108x

Annual Cash Flow Conversion Efficiency for i-SENS Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of i-SENS Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see i-SENS Inc market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩342.98 Billion
≈ $232.43 Million
₩22.96 Billion
≈ $15.56 Million
0.067x +55.73%
2023-12-31 ₩303.49 Billion
≈ $205.67 Million
₩13.05 Billion
≈ $8.84 Million
0.043x +84.64%
2022-12-31 ₩285.81 Billion
≈ $193.69 Million
₩6.65 Billion
≈ $4.51 Million
0.023x -63.73%
2021-12-31 ₩268.33 Billion
≈ $181.84 Million
₩17.22 Billion
≈ $11.67 Million
0.064x -59.30%
2020-12-31 ₩219.49 Billion
≈ $148.75 Million
₩34.61 Billion
≈ $23.46 Million
0.158x -17.49%
2019-12-31 ₩198.56 Billion
≈ $134.56 Million
₩37.95 Billion
≈ $25.72 Million
0.191x +76.94%
2018-12-31 ₩180.93 Billion
≈ $122.61 Million
₩19.54 Billion
≈ $13.24 Million
0.108x -21.41%
2017-12-31 ₩162.80 Billion
≈ $110.32 Million
₩22.38 Billion
≈ $15.16 Million
0.137x +75.44%
2016-12-31 ₩149.67 Billion
≈ $101.43 Million
₩11.73 Billion
≈ $7.95 Million
0.078x -54.15%
2015-12-31 ₩132.02 Billion
≈ $89.47 Million
₩22.56 Billion
≈ $15.29 Million
0.171x +13.76%
2014-12-31 ₩118.81 Billion
≈ $80.51 Million
₩17.85 Billion
≈ $12.09 Million
0.150x -3.22%
2013-12-31 ₩104.32 Billion
≈ $70.70 Million
₩16.19 Billion
≈ $10.97 Million
0.155x +108.16%
2012-12-31 ₩68.44 Billion
≈ $46.38 Million
₩5.10 Billion
≈ $3.46 Million
0.075x --

About i-SENS Inc

KQ:099190 Korea Healthcare Equipment & Supplies
Market Cap
$197.36 Million
₩291.23 Billion KRW
Market Cap Rank
#16578 Global
#705 in Korea
Share Price
₩21200.00
Change (1 day)
-2.53%
52-Week Range
₩14750.00 - ₩27000.00
All Time High
₩38452.83
About

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more